Delta Capital Management
VC Fund
Nashville, United States
Delta Capital Management is a VC fund in Nashville focused on Medical and Software. Delta Capital Management, LLC is a Memphis-based venture capital firm founded in 1992 that manages over $90 million in venture capital allocations from institutional investors and high net worth individuals through several partnerships. We invest primarily in early and expansion stage companies in the five-state region of Alabama, Arkansas,Louisiana, Mississippi and Tennessee. The firm also considers later stage opportunities across the broader southeastern U.S.Delta is actively managing two venture capital funds, Delta Venture Partners I, L.P. and Delta Venture Partners II, L.P., which total over $60 million.The firm focuses on several industries that have a meaningful presence in Delta's region and where the firm's partners have significant experience: * Health Care * Information* Technology* Supply Chain* Logistics* Business Services* Industrial Technology* Energy TechnologyWhile most of Delta's investment activities will focus on these industries, we may also invest in other industries where an attractive opportunity exists. We assist our portfolio companies in their strategic planning, management development, financing and then exit our investments through initial public offerings, strategic sales or recapitalizations.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Delta Capital Management invests in
Stages Delta Capital Management invests in
Countries Delta Capital Management invests in
Investment Focus
Industry
- Medical 1 (50%)
- Software 1 (50%)
- Biopharma 1 (50%)
- Health Care 1 (50%)
- Medical Device 1 (50%)
Stage
- Series B 1 (50%)
- Series E 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
NeuSpera Medical
|
NeuSpera Medical develops implantable medical device technology to treat chronic illnesses through minimally invasive solutions. NeuSpera focuses on bioelectronic medicine and has developed ultra-miniaturized implants using their proprietary Mid-Field Powering technology. This technology allows the implants to be powered externally, enabling deeperand more reliable neuromodulation treatments for conditions like Urinary Urgency Incontinence (UUI) and chronic peripheral nerve pain | $12M / Series B / Feb 20, 2019 | |
Bloodhound Software
|
Bloodhound Software is the leading claims editing service and analytics provider that offers a fully transparent, customizable, real-time service for all participants in the claims revenue cycle. ConVergence Point, its next-generation hosted claims editing service, can process a claim against 16 million edits across total patient history insubsecond response time. All ConVergence Point edits are open-sourced and based on national standards and can be configured to exactly match a payer’s reimbursement policies. Further, ConVergence Point provides a web portal for providers to see edits and correct claims before submission. | $3M / Series E / Nov 26, 2002 |
Co-Investors
6 Dimensions Capital
1 deal together
Action Potential Venture Capital
1 deal together
Alumni Ventures
1 deal together
A. M. Pappas & Associates
1 deal together
Noro-Moseley Partners
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Delta Capital Management invest in?
Delta Capital Management invests primarily in Medical, Software and Biopharma startups, most often at Series B and Series E stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Delta Capital Management last invest?
The most recent investment recorded for Delta Capital Management closed in Feb 2019. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
